| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03721e344a72026d125291e6c56c1be6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
1990-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18db85425fad16626c21dbc660efd8b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b29f6bed648ec7c5e5ad836e12ea7c18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da69a1e4fe761152938569d4a014271b |
| publicationDate |
1991-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9107185-A1 |
| titleOfInvention |
Inhibition of malignant cells having gm1 ganglioside sites by administration of cholera toxin |
| abstract |
The present invention relates to a method of identifying malignant cells having GM1 ganglioside sites and therefore susceptible to treatment with cholera toxin and a method of inhibiting growth of malignant cells having GM1 ganglioside sites by administration of cholera toxin. |
| priorityDate |
1989-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |